Clinical trial · Observational
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
NCT01976468CI-TRIAL-00039767unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators hypothesize that a low number of SCC in OTR will metastasize.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SCC metastasis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- SCC metastasis
- description
- organ transplant recipients
- interventionNames
- Other: SCC metastasis
Primary outcomes (1)
- measure
- SCC metastasis detection
- timeFrame
- two years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Organ-transplant recipients (OTR). * Histologically proven cutaneous invasive SCC at time of inclusion Exclusion criteria: * Lack of consent. * History of metastases of cutaneous SCC
References
Publications (0)
Data not yet available
No reference posted for this study.